FGFR3 genomic alterations, including S249C as the most common, are recognized oncogenic drivers in 10%-60% of bladder cancers depending on the disease stage. Onco3r Therapeutics BV recently reported ...

Bladder Cancer Awareness Month highlights the importance of early detection and support for patients, emphasizing the disease's prevalence and potential fatality. Treatment strategies differ by ...

or on the link below. The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers. Patients with genitourinary cancers such as kidney, bladder or prostate ...